We are pleased to inform you that Rothgordt & Cie. acted as Commercial Advisor to Equistone Partners Europe (formerly Barclays Private Equity) on the successful acquisition of CU UETIKON from CPH-Gruppe.
CU UETIKON is an established European producer of fine chemicals for the pharmaceutical and other industries. The company offers its partners a broad portfolio of proprietary and custom synthesis products, including advanced intermediates and active pharmaceutical ingredients (API). The company is located in Lahr, Germany and has been in the market for already more than 40 years. Equistone Partners Europe is an independent investment firm owned and managed by the former executives of Barclays Private Equity. The team of 33 investment professionals operates across France, Germany, Switzerland and the UK, investing as a strategic partner alongside management teams. In each of the markets, Equistone looks for strategic businesses with the potential to grow in value assisted by capital and experience. The company has a strong focus on change of ownership deals and aims to invest between €25m and €125m of equity in businesses with enterprise values of between €50m and €300m. |